-
Mashup Score: 0Zanubrutinib Associated With Longer Treatment Persistence, Duration, and TTD in Real-World MCL - 20 day(s) ago
Real-world treatment with zanubrutinib was linked to longer treatment persistence, duration, and time to discontinuation in mantle cell lymphoma.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Zanubrutinib Associated With Longer Treatment Persistence, Duration, and TTD in Real-World MCL - 21 day(s) ago
Real-world treatment with zanubrutinib was linked to longer treatment persistence, duration, and time to discontinuation in mantle cell lymphoma.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Zanubrutinib Associated With Longer Treatment Persistence, Duration, and TTD in Real-World MCL - 28 day(s) ago
Real-world treatment with zanubrutinib was linked to longer treatment persistence, duration, and time to discontinuation in mantle cell lymphoma.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
Zanubrutinib Associated With Longer Treatment Persistence, Duration, and TTD in Real-World MCL @gotoPER #HEM24 #lymsm https://t.co/4dQbmczaXt